Bgm Group(NASDAQ) BGM

Market Cap$114.20M

Since IPO (2025)-98%

5 Year-99%

1 Year-96%

1 Month+2%

$0.29

+6.11%

+0.02Today

Bgm Group last closing stock price
Metric	Price	Date
Last close	USD 0.29	2026-08-18

Bgm Group stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-1%	USD 0.29	2026-08-11
1 month	+2.27%	USD 0.28	2026-07-17
3 month	-1.34%	USD 0.29	2026-05-20
Year to date	-92.19%	USD 3.69	2025-12-31
1 year	-96.47%	USD 8.15	2025-08-18
3 year	-92.71%	USD 3.95	2023-08-18
5 year	-98.55%	USD 19.89	2021-08-19
Since inception	-97.73%	USD 11.95	2025-01-08

Bgm Group Financials at a Glance

Market Cap

$114.20M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

-$0.18

P/E Ratio

-1.54

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$0.29

Volume

102,788.319

Open

$0.26

Price

$0.29

Volume

102,788.319

Open

$0.26

Previous Close

$0.29

Daily Range

$0.25 - $0.29

52-Week Range

$0.25 - $11.80

Estimated Earnings Date

Mar 16, 2026

Dividend

$0.00

Beta (Volatility)

0.38 (Low)

Price

$0.29

Volume

102,788.319

Open

$0.26

Previous Close

$0.29

Daily Range

$0.25 - $0.29

52-Week Range

$0.25 - $11.80

Estimated Earnings Date

Mar 16, 2026

BGM News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bgm Group

BGM Group Ltd. is a pharmaceutical company based in Chengdu, China, specializing in the manufacturing and supply of active pharmaceutical ingredients (APIs) and traditional Chinese medicine (TCM) derivatives. Established in 2019, the company has developed a diverse portfolio that includes licorice-based products and organic fertilizers, catering to both healthcare and agricultural sectors.

Products and Services

Active pharmaceutical ingredients for various medical applications
Traditional Chinese medicine derivatives, including licorice extracts
Organic fertilizers designed to enhance crop yields

Growth Outlook

Recent revenue growth of 14% year-over-year in Q2 2025
Expansion into new markets anticipated to drive future sales
Investment in R&D expected to enhance product offerings

Financial Highlights

Q2 2025 revenue of $14.31 million, up from $12.56 million in Q2 2024
Gross profit margin improved to 14.5% in Q2 2025
Current ratio of 3.39 indicates strong liquidity position

BGM Group Ltd. operates in the healthcare sector, focusing on drug manufacturing, particularly in specialty and generic drugs. The company has shown promising growth, with a notable increase in revenue in the most recent quarter. The improvement in gross profit margin reflects effective cost management and operational efficiency. The strong current ratio suggests that BGM Group is well-positioned to meet its short-term obligations, providing a solid foundation for future growth. The company's commitment to research and development is expected to further enhance its product offerings, making it an intriguing option for potential investors interested in the pharmaceutical industry.

AI Generated • Jul 23, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

471

CEO

Chen Xin

Website

www.bgm.ltd

Headquarters

Chengdu, SIC 610200, CN

BGM Financials

Key Financial Metrics (TTM)

Gross Margin

12.79%

Operating Margin

-33.18%

Net Income Margin

-52.59%

Return on Equity

-6.96%

Return on Capital

-3.20%

Return on Assets

-4.60%

Earnings Yield

-64.94%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$114.20M

Shares Outstanding

420.62M

Volume

102.79K

Avg. Volume

427.12K

Financials (TTM)

Gross Profit

$6.26M

Operating Income

-$13.26M

EBITDA

-$11.80M

Operating Cash Flow

-$2.37M

Capital Expenditure

-$2.07M

Free Cash Flow

-$4.44M

Cash & ST Invst.

$10.82M

Total Debt

$1.94M

Bgm Group Performance Analysis

Bgm Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-09-30	USD 64,855,025	13.6%
2023	2023-09-30	USD 46,471,478	-28.3%
2024	2024-09-30	USD 25,097,951	-46.0%
2025	2025-09-30	USD 37,919,425	51.1%

Bgm Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-03-31	N/A
Q4	2024-09-30	N/A
Q2	2025-03-31	N/A
Q4	2025-09-30	65.0%

Bgm Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-09-30	USD 0.15	-65.8%
2023	2023-09-30	USD -1.09	N/A
2024	2024-09-30	USD -0.20	-81.6%
2025	2025-09-30	USD -0.18	-11.8%

Bgm Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2024-03-31	N/A
Q4	2024-09-30	N/A
Q2	2025-03-31	N/A
Q4	2025-09-30	-451.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$23.61M

N/A

Gross Profit

$2.78M

N/A

Gross Margin

11.77%

N/A

Market Cap

$114.20M

N/A

Market Cap/Employee

$383.22K

N/A

Employees

298

N/A

Net Income

-$19.08M

N/A

EBITDA

-$9.32M

N/A

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

$10.82M

-51.8%

Total Debt

$1.94M

+235.5%

Accounts Receivable

$17.05M

+168.3%

Inventory

$23.68M

+374.4%

Long Term Debt

$79.31K

+222.7%

Short Term Debt

$1.86M

+236.1%

Return on Assets

-4.60%

N/A

Return on Invested Capital

-3.21%

N/A

Free Cash Flow

-$363.74K

N/A

Operating Cash Flow

$683.66K

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

QDELQuidelOrtho Corporation

QDELQuidelOrtho Corporation$13.43-7.89%

PRCTPROCEPT BioRobotics Corporation

PRCTPROCEPT BioRobotics Corporation$21.32+1.09%

PAHCPhibro Animal Health Corporation

PAHCPhibro Animal Health Corporation$34.65+0.06%

ANIPANI Pharmaceuticals, Inc.

ANIPANI Pharmaceuticals, Inc.$76.87+1.14%

AVDLAvadel Pharmaceuticals plc

AVDLAvadel Pharmaceuticals plc$21.64+0.00%

MESOMesoblast Limited

MESOMesoblast Limited$16.67-2.06%

CLOVClover Health Investments, Corp.

CLOVClover Health Investments, Corp.$4.23-1.10%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.48-0.02%

INTCIntel

INTCIntel$96.69-0.07%

NOKNokia

NOKNokia$10.39-0.04%

NVDANvidia

NVDANvidia$219.74-0.02%

PATHUiPath

PATHUiPath$15.58-0.03%

NUNu Holdings

NUNu Holdings$14.35-0.03%

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF

SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF$129.10-0.15%

Questions About BGM

What is the current price of Bgm Group?

Bgm Group is trading at $0.29 per share.

What is the 52-week range for Bgm Group?

Over the past 52 weeks, Bgm Group has traded between $0.25 and $11.80.

How much debt does Bgm Group have?

As of the most recent reporting period, Bgm Group reported total debt of $1.94M.

How much cash does Bgm Group have on hand?

Bgm Group reported $9.82M in cash and cash equivalents in its most recent financial results.

What is Bgm Group’s dividend yield?

Bgm Group does not currently have a dividend yield.

Bgm Group(NASDAQ) BGM

Bgm Group Financials at a Glance

BGM News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Bgm Group

BGM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Bgm Group Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About BGM

What is the current price of Bgm Group?

What is the 52-week range for Bgm Group?

How much debt does Bgm Group have?

How much cash does Bgm Group have on hand?

What is Bgm Group’s dividend yield?

Premium Investing Services